Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemia

Current Opinion in Lipidology

Volumn 7, Issue 6, 1996, Pages 381-384

  Gordon, Bruce R ^a   Saal, Stuart D ^a  

^a ROGOSIN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; DEXTRAN SULFATE; HEPARIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

APHERESIS; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; FILTRATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IMMUNOADSORPTION; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030499843     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199612000-00007     Document Type: Short Survey

References (31)

1. Schuff-Werner P, Armstrong VW, Eisenhauer TH, Thiery J, Seidel D: Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). Contrib Infus Ther 1988, 23:118-126.
2. Lupien PJ, Moorjani S, Awad J: A new approach to the management of familial hypercholesterolemia: removal of plasma cholesterol based on the principle of affinity chromatography. Lancet 1976, i:1261-1264.
3. Stoffel W, Borberg H, Greve V: Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet 1981, ii:1005-1007.
4. Yokoyama S, Hayashi R, Satani M, Yamamoto A: Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985, 5:613-622.
5. Matsuda Y, Malchesky PS, Nose Y: Low-density lipoprotein removal methods by membranes and future perspectives. Artif Organs 1996, 20:346-354.
6. Bosch T: Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results. Artif Organs 1996, 20:344-345. A new method for performing specific removal of LDL-cholesterol is described. Initial separation of blood into cells and plasma is not required as the columns are compatible with whole blood.
7. Matsuda Y, Sueoka A, Nose Y: An effective LDL removal filter for the treatment of hyperlipidemia. Artif Organs 1995, 19:129-134.
8. Pokrovsky SN, Sussekov AV, Adamova IY, Afanasieva OI, Benevolenskaya GF, Konovalov GA, Kukharchuk VV: Development of immunosorbents for apoB-containing lipoproteins apheresis. Artif Organs 1995, 19:500-505. A system for binding and removal of Lp(a) is presented. The procedure uses columns containing an immobilized purified antibody specific for Lp(a).
9. Olbricht CJ, Schaumann D, Fischer D: Anaphylactoid reactions, LDL-apheresis with dextran sulphate, and ACE inhibitors. Lancet 1992, 340:908-909.
10. Kojima S, Iwase N, Yoshitomi Y, Ogi M, Osada M, Limura M, Kuramochi M: Changes in bradykinin and other vasoactive factors during LDL apheresis. Jpn J Apheresis 1996, 15:124-125.
11. Kojima S, Shiba M, Kuramochi M, Yamamoto A: Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis. Artif Organs 1995, 19:135-139.
12. Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, Corti MC, Dinsenbacher A, Eisenhauer T, Grutzmacher P, Keller C, Kettner U et al.: The HELP-LDL-apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 1994, 24:724-732.
13. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T et al.: Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992, 95:1-13.
14. Borberg H, Oette K: Experience with and conclusions from three different trials on low density lipoprotein apheresis. In Therapeutic plasmapheresis (XII). Edited by Agishi T, Kawamura A, Mineshima M. Utrecht: VSP; 1993:13-20.
15. Thompson GR, Maher VMG, Mathews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ et al: Familial hypercholesterolaemia regression study: a randomised trial of low-density-lipoprotein apheresis. Lancet 1995, 345:811-816. A randomized controlled trial that compared patients achieving equal LDL-cholesterol levels using either biweekly LDL-apheresis and single drug treatment with combination lipid-lowering drugs. Angiographic results were similar in the two groups. Lp(a) lowering did not correlate with disease improvement.
16. Kroon AA, Aengevaeren WRM, van der Werf T, Uijen GJH, Reiber JHC, Bruschke AVG, Stalenhoef AFH: LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996, 93:1826-1835. A 2-year study compared patients receiving LDL-apheresis plus simvastatin with those receiving simvastatin alone. No differences in angiographic end points were observed although the LDL-apheresis group had more improvement in electrocardiogram stress tests.
17. Park JW, Vermeltfoort M, Braun P, May E, Merz M: Regression of transplant coronary artery disease during chronic HELP therapy: a case study. Atherosclerosis 1995, 115:1-8.
18. Thiery J, Meiser B, Wenke K, Engelschalk C, Reichart B, Seidel D: Heparin-induced extracorporeal low-density-lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia. Transplant Proc 1995, 27:1950-1953. A rationale for the use of LDL-apheresis in patients who have received heart transplantation is presented. Initial results suggest a favorable response to therapy.
19. Daida H, Young JL, Yokoi H, Kanoh T, Ishiwata S, Kato K, Nishikawa H, Takatsu F, Kato H, Kutsumi Y et al.: Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Am J Cardiol 1994, 73:1037-1040.
20. Adachi H, Niwa A, Shinoda T: Prevention of restenosis after coronary angioplasty with low-density lipoprotein apheresis. Artif Organs 1995, 19:1243-1247.
21. Uno H, Ueki Y, Murashima J, Miyake S, Tominaga Y, Eguchi K, Yano K: Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance. Atherosclerosis 1995, 116:93-102. Patients with peripheral vascular disease had clinical improvement as a result of LDL-apheresis therapy. Reduction in expression of adhesion molecules was demonstrated and postulated as a possible mechanism for clinical improvement.
22. Sato Y, Agishi T: Low-density lipoprotein adsorption for arteriosclerotic patients. Artif Organs 1996, 20:324-327.
23. Brunner R, Widder RA, Walter P, Borberg H, Oette K: Change in hemorrheological and biochemical parameters following membrane differential filtration. Int J Artif Organs 1995, 18:794-798.
24. Aengevaeren WRM, Kroon AA, Stalenhoef AF, Uijen GJ, van der Werf T: Effect of low-density-lipoprotein apheresis on coronary anatomy and regional myocardial blood flow [Abstract]. J Am Coll Cardiol 1996, 27(suppl A):90A.
25. Igarashi K, Horimoto M, Takenaka T, Inoue H, Miyata S: Acute cholesterol lowering therapy with LDL-apheresis improves endothelial function of the coronary microcirculation [Abstract]. Circulation 1995, 92(Suppl I)::I452.
26. Thompson GR, Lowenthal R, Myant NB: Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1975, i:1203-1211.
27. McNamara DJ, Ahrens Jr EF, Kolb R, Brown CD, Parker TS, Davidson NO, Samuel P, McVie RM: Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool size. Proc Natl Acad Sci USA 1983, 80:564-568.
28. Bilheimer DW, Grundy SM, Starzl TE, Brown MS: Liver transplantation to provide low density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984, 311:1658-1664.
29. Buchwald H: Surgical operation to lower circulating cholesterol. Circulation 1963, 28:649.
30. Grossman M, Rader DJ, Muller DWM, Kolansky DM, Kozarsky K, Clark BJ III, Stein EA, Lupien PJ, Brewer HB Jr, Raper SE, Wilson JM: A pilot study of ex-vivo gene therapy for homozygous familial hypercholesterolemia Nature Med 1995, 1:1148-1154.
31. Marais AD, Firth JC, Neuwirth C, Taylor GW, Thompson GR: Apheresis plus atorvastatin: a hard act for gene therapy to follow? Presented at the 66th Congress of the European Atherosclerosis Society, Florence, Italy, 13-17 July, 1996.